General Information of Drug (ID: DMYMGBA)

Drug Name
GC-14 Drug Info
Indication
Disease Entry ICD 11 Status REF
Discovery agent N.A. Investigative [1]
Cross-matching ID
PubChem CID
23724977
TTD Drug ID
DMYMGBA

Molecule-Related Drug Atlas

Molecule-Related Drug Atlas
Molecule Type:
DTT
Drug Status:
Clinical Trial Drug(s)
Discontinued Drug(s)
Investigative Drug(s)
Drug Name Drug ID Indication ICD 11 Highest Status REF
B7-2/GM-CSF DM0LKHV Dementia 6D80-6D86 Phase 1 [2]
KB-5359 DMM7S3V Lipid metabolism disorder 5C52.Z Terminated [3]
Neplanocin A DMXULGK Discovery agent N.A. Investigative [1]
NH-3 DMYAB79 Discovery agent N.A. Investigative [1]
NH-4 DMSUZFO Discovery agent N.A. Investigative [1]

Molecular Interaction Atlas of This Drug

Molecular Interaction Atlas

Drug Therapeutic Target (DTT)
DTT Name DTT ID UniProt ID MOA REF
Thyroid hormone receptor (THR) TTQWUPT NOUNIPROTAC Antagonist [1]

References

1 Design of thyroid hormone receptor antagonists from first principles. J Steroid Biochem Mol Biol. 2002 Dec;83(1-5):59-73.
2 Sobetirome: a case history of bench-to-clinic drug discovery and development. Heart Fail Rev. 2010 Mar;15(2):177-82.
3 Drugs@FDA. U.S. Food and Drug Administration. U.S. Department of Health & Human Services.